文献速递肝病

脂毒性肝细胞外泌体miR-192-5p通过Rictor/Akt/FoxO1激活巨噬细胞

Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Hepatology · 2020-05-16

该研究探讨非酒精性脂肪性肝病(NAFLD)中肝细胞与巨噬细胞交互机制。发现脂毒性肝细胞释放富含miR-192-5p的外泌体,通过抑制Rictor/Akt/FoxO1信号促进M1巨噬细胞活化与肝脏炎症,血清外泌体miR-192-5p与疾病进展相关,可能作为无创标志物和治疗靶点。

要点

  • 脂毒性肝细胞外泌体miR-192-5p促进M1巨噬细胞活化与肝脏炎症。
  • 血清miR-192-5p水平与NAFLD患者肝脏炎症活动评分及疾病进展正相关。
  • 外泌体miR-192-5p通过抑制Rictor/Akt/FoxO1信号诱导炎症反应。

核心结论

  • 肝细胞来源外泌体miR-192-5p通过调控Rictor/Akt/FoxO1信号在NAFLD促炎巨噬细胞活化和疾病进展中起关键作用。
  • 血清外泌体miR-192-5p可能是非酒精性脂肪性肝炎的潜在无创生物标志物和治疗靶点。

研究设计与样本

  • 研究纳入NAFLD患者和高脂高胆固醇饮食喂养大鼠模型,并开展细胞实验探讨肝细胞外泌体对巨噬细胞的作用机制。

主要发现

  • NAFLD患者血清miR-192-5p水平与肝脏炎症活动评分和疾病进展呈正相关。
  • 在高脂高胆固醇饮食大鼠模型中,血清miR-192-5p水平、M1巨噬细胞数量及肝脏促炎介质表达与疾病进展相关。
  • 脂毒性肝细胞释放更多富含miR-192-5p的外泌体,诱导CD11b+/CD86+ M1巨噬细胞活化并增加诱导型一氧化氮合酶、白细胞介素6和肿瘤坏死因子α表达。
  • 肝细胞来源外泌体miR-192-5p抑制Rictor蛋白表达,进而抑制Akt和FoxO1磷酸化水平,导致FoxO1激活并诱导炎症反应。

临床怎么用

  • 血清外泌体miR-192-5p或可作为评估NAFLD疾病进展的无创生物标志物。
  • 靶向外泌体miR-192-5p及其下游Rictor/Akt/FoxO1信号可能为NASH治疗提供新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Hepatic macrophages can be activated by many factors such as gut-derived bacterial components and factors released from damaged hepatocytes. Macrophage polarization toward a proinflammatory phenotype (M1) represents an important event in the disease progression of nonalcoholic fatty liver disease (NAFLD). However, the underlying molecular mechanisms remain incompletely understood. Exosomes have been identified as important mediators for cell-cell communication by transferring various biological components such as microRNAs (miRs), proteins, and lipids. The role of exosomes in crosstalk between hepatocytes and macrophages in disease progression of NAFLD is yet to be explored. APPROACH AND RESULTS: In the present study, we reported that lipotoxic injury-induced release of hepatocyte exosomes enriched with miR-192-5p played a critical role in the activation of M1 macrophages and hepatic inflammation. Serum miR-192-5p levels in patients with NAFLD positively correlated with hepatic inflammatory activity score and disease progression. Similarly, the serum miR-192-5p level and the number of M1 macrophages, as well as the expression levels of the hepatic proinflammatory mediators, were correlated with disease progression in high-fat high-cholesterol diet-fed rat models. Lipotoxic hepatocytes released more miR-192-5p-enriched exosomes than controls, which induced M1 macrophage (cluster of differentiation 11b-positive [CD11b+ ]/CD86+ ) activation and increase of inducible nitric oxide synthase, interleukin 6, and tumor necrosis factor alpha expression. Furthermore, hepatocyte-derived exosomal miR-192-5p inhibited the protein expression of the rapamycin-insensitive companion of mammalian target of rapamycin (Rictor), which further inhibited the phosphorylation levels of Akt and forkhead box transcription factor O1 (FoxO1) and resulted in activation of FoxO1 and subsequent induction of the inflammatory response. CONCLUSIONS: Hepatocyte-derived exosomal miR-192-5p plays a critical role in the activation of proinflammatory macrophages and disease progression of NAFLD through modulating Rictor/Akt/FoxO1 signaling. Serum exosomal miR-192-5p represents a potential noninvasive biomarker and therapeutic target for nonalcoholic steatohepatitis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Liu XL, Pan Q, Cao HX, et al. Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. Hepatology. 2020. PMID: 31782176. doi:10.1002/hep.31050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。